Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2003.026989v1, 2004; 10.1373/clinchem.2003.026989
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2003.026989v1
50/5/874    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cole, L. A.
Right arrow Articles by Cembrowski, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cole, L. A.
Right arrow Articles by Cembrowski, G. S.

Received on September 5, 2003
Accepted on February 20, 2004

Endocrinology and Metabolism

Between-Method Variation in Human Chorionic Gonadotropin Test Results

Laurence A. Cole 1*, Jaime M. Sutton 1, Trefor N. Higgins 2, George S. Cembrowski 3

1 USA hCG Reference Service, Department of Obstetrics and Gynecology, University of New Mexico, Albuquerque, NM 87131
2 Dynacare Kasper Medical Laboratories, Edmonton, Alberta, Canada
3 Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada

* To whom correspondence should be addressed. E-mail: larry{at}hcglab.com.

Background: Results on sera and calibrators vary 1.4- to 2.3-fold among commercial human chorionic gonadotropin (hCG) assays. The relative contributions of calibrators, standards, hCG charge isoforms, and major structural variants to this variation have not been quantified.

Methods: Purified hCG was separated by isoelectric focusing into four fractions with pI ranges of 3-4, 4-5, 5-6, and 6-7. These four fractions together with pure hCG, hyperglycosylated hCG, hCG {beta}-subunit (hCGb), nicked hCG, and hCGb core fragment (hCGbcf) were tested in nine commonly used commercial serum assays for hCG. The compositions of pure hCG preparations, standards, and commercial hCG preparations were determined by immunoassay.

Results: The three pure hCG preparations and the four hCG charge isoforms each showed parallel responses in the nine commercial hCG assays. Although wide variations were found in the detection of hCG structural variants by the nine assays (hyperglycosylated hCG, hCGb, nicked hCG, and hCGbcf), this did not correlate with the between-method variation observed in results for the three pure hCG preparations. Commercial preparations of hCG and calibrators showed great variation in their content of hCG structural variants.

Conclusions: Intermethod differences in hCG results were not explained by changes in responses attributable to hCG charge isoforms or to hCG structural variants, but wide variation was observed in concentrations of hCG structural variants in calibrators and in detection of these structural variants. Differences in assay specificity and in composition of the calibrators are the most likely sources of between-method variation.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
C. M. Sturgeon, P. Berger, J.-M. Bidart, S. Birken, C. Burns, R. J. Norman, U.-H. Stenman, and on behalf of the IFCC Working Group on hCG
Differences in Recognition of the 1st WHO International Reference Reagents for hCG-Related Isoforms by Diagnostic Immunoassays for Human Chorionic Gonadotropin
Clin. Chem., August 1, 2009; 55(8): 1484 - 1491.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. M. Gronowski and D. G. Grenache
Characterization of the hCG Variants Recognized by Different hCG Immunoassays: An Important Step Toward Standardization of hCG Measurements
Clin. Chem., August 1, 2009; 55(8): 1447 - 1449.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
A. M. Gronowski, M. Cervinski, U.-H. Stenman, A. Woodworth, L. Ashby, and M. G. Scott
False-Negative Results in Point-of-Care Qualitative Human Chorionic Gonadotropin (hCG) Devices Due to Excess hCG{beta} Core Fragment
Clin. Chem., July 1, 2009; 55(7): 1389 - 1394.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S.F. de Medeiros and R.J. Norman
Human choriogonadotrophin protein core and sugar branches heterogeneity: basic and clinical insights
Hum. Reprod. Update, January 1, 2009; 15(1): 69 - 95.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. M. Ferguson, B. Ford, and A. M. Gronowski
Method Validation for Cerebral Spinal Fluid Human Chorionic Gonadotropin Measurement with the Advia Centaur(R)
Clin. Chem., August 1, 2008; 54(8): 1408 - 1409.
[Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
C. L Buckner, L. Wilson, and C. N. Papadea
An Unusual Cause of Elevated Serum Total {beta}hCG
Ann. Clin. Lab. Sci., January 1, 2007; 37(2): 186 - 191.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
U.-H. Stenman, A. Tiitinen, H. Alfthan, and L. Valmu
The classification, functions and clinical use of different isoforms of HCG
Hum. Reprod. Update, November 1, 2006; 12(6): 769 - 784.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
U.-H. Stenman
Standardization of Assays for Human Chorionic Gonadotropin
Clin. Chem., May 1, 2004; 50(5): 798 - 800.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the American Association for Clinical Chemistry.